Synthetic retinoid AM80 inhibits IL-17 production of gamma delta T cells and ameliorates biliary atresia in mice.


Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
12 2020
Historique:
received: 29 03 2020
revised: 03 08 2020
accepted: 10 08 2020
entrez: 19 1 2021
pubmed: 20 1 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Recent evidence suggests that Interleukin (IL)-17-producing gamma delta ( Here, we established an in vitro system, enabling investigations of the effect of AM80 on the IL-17 production of AM80 efficiently reduced IL-17 production by murine Retinoids are very efficient in down-regulating IL-17 production by Biliary atresia (BA) is a rare disease which affects infants, causing progressive liver failure in most children, and is the most common indication for paediatric liver transplantation. We have previously demonstrated that IL-17, produced by

Sections du résumé

BACKGROUND & AIMS
Recent evidence suggests that Interleukin (IL)-17-producing gamma delta (
METHODS
Here, we established an in vitro system, enabling investigations of the effect of AM80 on the IL-17 production of
RESULTS
AM80 efficiently reduced IL-17 production by murine
CONCLUSIONS
Retinoids are very efficient in down-regulating IL-17 production by
LAY SUMMARY
Biliary atresia (BA) is a rare disease which affects infants, causing progressive liver failure in most children, and is the most common indication for paediatric liver transplantation. We have previously demonstrated that IL-17, produced by

Identifiants

pubmed: 33463083
doi: 10.1111/liv.14639
doi:

Substances chimiques

Benzoates 0
Interleukin-17 0
Retinoids 0
Tetrahydronaphthalenes 0
tamibarotene 08V52GZ3H9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3031-3041

Informations de copyright

© 2020 The Authors. Liver International published by John Wiley & Sons Ltd.

Références

Leonhardt J, Kuebler JF, Leute PJ, et al. ,Biliary atresia: lessons learned from the voluntary German registry. European journal of pediatric surgery: official journal of Austrian Association of Pediatric Surgery [et al.]. = Zeitschrift fur Kinderchirurgie. 2011;21(2):82-87.
Mieli-Vergani G, Vergani D. Biliary atresia. Semin Immunopathol. 2009;31(3):371-381.
Bezerra JA. Biliary atresia-translational research on key molecular processes regulating biliary injury and obstruction. Chang Gung Med J. 2006;29(3):222-230.
Alvarez F. Is biliary atresia an immune mediated disease? J Hepatol. 2013;59(4):648-650.
Feldman AG, Mack CL. Biliary atresia: Cellular dynamics and immune dysregulation. Semin Pediatr Surg. 2012;21(3):192-200.
Rauschenfels S, Krassmann M, Al-Masri AN, et al. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr. 2009;168(4):469-476.
Petersen C. Biliary atresia: The animal models. Semin Pediatr Surg. 2012;21(3):185-191.
Petersen C, Davenport M. Aetiology of biliary atresia: What is actually known? Orphanet J Rare Dis. 2013;8:128.
Mack CL, Tucker RM, Sokol RJ, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004;56(1):79-87.
Feldman AG, Tucker RM, Fenner EK, Pelanda R, Mack CL. B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia. PLoS One. 2013;8(8):e73644.
Li J, Bessho K, Shivakumar P, et al. Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Investig. 2011;121(11):4244-4256.
Klemann C, Schroder A, Dreier A, et al. Interleukin 17, Produced by gammadelta T Cells, contributes to hepatic inflammation in a mouse model of biliary atresia and is increased in livers of patients. Gastroenterology. 2016;150(1):229-241. e5.
Bai A, Lu N, Guo Y, Liu Z, Chen J, Peng Z. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009;86(4):959-969.
Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol. 2007;37(9):2396-2399.
Elias KM, Laurence A, Davidson TS, et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 2008;111(3):1013-1020.
Klemann C, Raveney BJE, Klemann AK, et al. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am J Pathol. 2009;174(6):2234-2245.
Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309(5734):623-626.
Koenecke C, Chennupati V, Schmitz S, Malissen B, Forster R, Prinz I. In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells. Eur J Immunol. 2009;39(2):372-379.
Rong S, Hueper K, Kirsch T, et al. Renal PKC-epsilon deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-alpha-dependent inhibition of apoptosis and inflammation. Am J Physiol Renal Physiol. 2014;307(6):F718-F726.
Korn T, Petermann F. Development and function of interleukin 17-producing gammadelta T cells. Ann N Y Acad Sci. 2012;1247:34-45.
Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31(2):331-341.
Haas JD, Ravens S, Duber S, et al. development of interleukin-17-producing gammadelta T cells is restricted to a functional embryonic wave. Immunity. 2012;37(1):48-59.
Ribot JC, deBarros A, Pang DJ, et al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol. 2009;10(4):427-436.
Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60(5):1090-1096.
Karlmark KR, Weiskirchen R, Zimmermann HW, et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology. 2009;50(1):261-274.
Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173-182.
Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol. 2008;180(1):214-221.
Wragg KM, Tan H-X, Kristensen AB, et al. High CD26 and low CD94 expression identifies an IL-23 responsive Vδ2+ T cell subset with a MAIT cell-like transcriptional profile. Cell Rep. 2020;31(11):107773.
Ness-Schwickerath KJ, Morita CT. Regulation and function of IL-17A- and IL-22-producing gammadelta T cells. Cellular and molecular life sciences: CMLS. 2011;68(14):2371-2390.
Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001;194(4):519-527.
Ishigame H, Kakuta S, Nagai T, et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30(1):108-119.
Ranasinghe C, Trivedi S, Wijesundara DK, Jackson RJ. IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants. Cytokine Growth Factor Rev. 2014;25(4):437-442.
Racke MK, Burnett D, Pak SH, et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. Journal of immunology. 1995;154(1):450-458.
Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol. 2008;181(4):2277-2284.
Ness-Schwickerath KJ, Jin C, Morita CT. Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol. 2010;184(12):7268-7280.
Maggi L, Santarlasci V, Capone M, et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol. 2010;40(8):2174-2181.
Tan L, Sandrock I, Odak I, et al. Single-cell transcriptomics identifies the adaptation of Scart1(+) Vgamma6(+) T cells to skin residency as activated effector cells. Cell Rep. 2019;27(12):3657-3671. e4.
Ponomarev ED, Dittel BN. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. Journal of immunology. 2005;174(8):4678-4687.
Malik S, Want MY, Awasthi A. The emerging roles of gamma-delta t cells in tissue inflammation in experimental autoimmune encephalomyelitis. Front Immunol. 2016;7:14.
Hammerich L, Bangen JM, Govaere O, et al. Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology. 2014;59(2):630-642.
Shi T, Zhang T, Zhang L, Yang Y, Zhang H, Zhang F. The distribution and the fibrotic role of elevated inflammatory Th17 cells in patients with primary biliary cirrhosis. Medicine. 2015;94(44):e1888.
Vantourout P, Hayday A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol. 2013;13(2):88-100.
Yang Y, Liu Y-J, Tang S-T, et al. Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia. Pediatr Surg Int. 2013;29(12):1249-1260.
Zheng L, Chu J, Shi Y, et al. Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. Cell Biosci. 2013;3(1):46.
Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol. 2010;7(4):250-254.

Auteurs

Nora Möhn (N)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.

Elena Bruni (E)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Arne Schröder (A)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.

Stephanie Frömmel (S)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.

Faikah Gueler (F)

Department of Nephrology, Hannover Medical School, Hannover, Germany.

Gertrud Vieten (G)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.

Immo Prinz (I)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Joachim F Kuebler (JF)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.

Claus Petersen (C)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.

Christian Klemann (C)

Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany.
Department of Pediatric Pulmonology, Allergy and Neonatology, Hannover Medical School, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH